Background
PTC, Zoran
THYROID, RECURRENCE, DIFFERENTIATED THYROID CARCINOMA, PAPILLARY THYROID CARCINOMA
Edited by: Dario de Biase, University of Bologna, ItalyReviewed by: Zoran Gluvic, University of Belgrade, Serbia; Khawla S. Al-Kuraya, King Faisal Specialist Hospital and Research Centre, Saudi Arabia†These authors have contributed equally to this work and share first authorshipThe 2015 American Thyroid Association guidelines proposed recurrence risk stratification of differentiated thyroid carcinoma, including papillary thyroid carcinoma (PTC), but this stratification excluded non–initial treatment patients with worse outcomes. This study aimed to explore the potential risk factors for recurrence in PTC and develop a predictive model for both initial and non–initial treatment of patients with PTC.